To meet our customers’ needs we have expanded Asper Ophthalmics testing portfolio with two new tests for Choroideremia and X-Linked Retinoschisis. Sequencing-based tests cover the entire coding region of the CHM gene and the RS1 gene associated respectively with above-mentioned diseases. Read more https://www.asperbio.com/asper-ophthalmics/choroideremia and https://www.asperbio.com/asper-ophthalmics/x-linked-retinoschisis.